E Petersdorf

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. ncbi request reprint Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors
    E W Petersdorf
    Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA98109, USA
    Tissue Antigens 69:25-30. 2007
  2. ncbi request reprint 14thInternational HLA and Immunogenetics Workshop: report on hematopoietic cell transplantation
    E Petersdorf
    Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Tissue Antigens 69:17-24. 2007
  3. ncbi request reprint HLA matching in hematopoietic cell transplantation
    E M Mickelson
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Hum Immunol 61:92-100. 2000
  4. ncbi request reprint Hematopoietic stem cell transplants from unrelated donors
    J A Hansen
    Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Immunol Rev 157:141-51. 1997
  5. ncbi request reprint The role of HLA matching in hematopoietic cell transplantation
    J A Hansen
    Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Rev Immunogenet 1:359-73. 1999
  6. ncbi request reprint Genomics of unrelated-donor hematopoietic cell transplantation
    E Petersdorf
    University of Washington, School of Medicine, 1959 NE Pacific Street, Seattle, Washington 98105, USA
    Curr Opin Immunol 13:582-9. 2001
  7. ncbi request reprint MHC microsatellite diversity and linkage disequilibrium among common HLA-A, HLA-B, DRB1 haplotypes: implications for unrelated donor hematopoietic transplantation and disease association studies
    M Malkki
    The Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Tissue Antigens 66:114-24. 2005
  8. ncbi request reprint Immune response gene polymorphisms in unrelated donor hematopoietic cell transplantation
    M Malkki
    Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Tissue Antigens 69:50-3. 2007
  9. ncbi request reprint Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors
    Y Morishima
    Aichi Cancer Center, Nagoya, Japan
    Tissue Antigens 69:31-5. 2007
  10. ncbi request reprint Clinical importance of HLA-DPB1 in haematopoietic cell transplantation
    B E Shaw
    Department of Haematology, Nottingham City Hospital, Nottingham, UK
    Tissue Antigens 69:36-41. 2007

Collaborators

Detail Information

Publications25

  1. ncbi request reprint Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors
    E W Petersdorf
    Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA98109, USA
    Tissue Antigens 69:25-30. 2007
    ..The permissibility of a given HLA mismatch is in part defined by the locus and by disease risk...
  2. ncbi request reprint 14thInternational HLA and Immunogenetics Workshop: report on hematopoietic cell transplantation
    E Petersdorf
    Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Tissue Antigens 69:17-24. 2007
    ....
  3. ncbi request reprint HLA matching in hematopoietic cell transplantation
    E M Mickelson
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Hum Immunol 61:92-100. 2000
    ..The use of these methods to optimize donor selection will improve both donor identification and the success of unrelated donor transplants...
  4. ncbi request reprint Hematopoietic stem cell transplants from unrelated donors
    J A Hansen
    Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Immunol Rev 157:141-51. 1997
    ..In order to provide transplants for all patients, improved methods for GVHD prophylaxis are needed that will make it possible to safely perform transplants even across limited degrees of HLA disparity...
  5. ncbi request reprint The role of HLA matching in hematopoietic cell transplantation
    J A Hansen
    Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Rev Immunogenet 1:359-73. 1999
    ..There remain, however, important unanswered questions about the relative importance of different HLA loci in matching strategies, as well as incomplete information about permissible limits of mismatching in different patient populations...
  6. ncbi request reprint Genomics of unrelated-donor hematopoietic cell transplantation
    E Petersdorf
    University of Washington, School of Medicine, 1959 NE Pacific Street, Seattle, Washington 98105, USA
    Curr Opin Immunol 13:582-9. 2001
    ..Delineation of the function of these markers as transplantation determinants may provide alternative means for optimizing the results of hematopoietic cell transplantation...
  7. ncbi request reprint MHC microsatellite diversity and linkage disequilibrium among common HLA-A, HLA-B, DRB1 haplotypes: implications for unrelated donor hematopoietic transplantation and disease association studies
    M Malkki
    The Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Tissue Antigens 66:114-24. 2005
    ..Markers with high HSH values will be most informative in studies investigating MHC region disease-susceptibility genes where HLA haplotypic effects are known to exist...
  8. ncbi request reprint Immune response gene polymorphisms in unrelated donor hematopoietic cell transplantation
    M Malkki
    Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Tissue Antigens 69:50-3. 2007
    ..The International Histocompatibility Working Group (IHWG) in hematopoietic cell transplantation took a candidate gene approach to define the risks associated with genetic variation for a panel of well-characterized IRG...
  9. ncbi request reprint Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors
    Y Morishima
    Aichi Cancer Center, Nagoya, Japan
    Tissue Antigens 69:31-5. 2007
    ....
  10. ncbi request reprint Clinical importance of HLA-DPB1 in haematopoietic cell transplantation
    B E Shaw
    Department of Haematology, Nottingham City Hospital, Nottingham, UK
    Tissue Antigens 69:36-41. 2007
    ..33; P-value = <0.0001], while protecting against disease relapse (HR: 0.82, P-value = 0.01). These data support an immunogenic role for HLA-DPB1 in HCT and the need for pretransplant tissue typing at this locus...
  11. ncbi request reprint Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component
    K C Hsu
    Adult Allogeneic Blood and Marrow Transplantation Service, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Tissue Antigens 69:42-5. 2007
    ..KIR genotyping for unrelated donors and recipients will clarify the role of these receptors in transplant outcome...
  12. ncbi request reprint MHC class I, II, and III microsatellite marker matching and survival in unrelated donor hematopoietic cell transplantation
    M Malkki
    Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Tissue Antigens 69:46-9. 2007
    ..Retrospective analysis of human leukocyte antigen-identical unrelated donor transplants provided a homogeneous population to measure Msat-associated risks of mortality...
  13. ncbi request reprint Tissue typing in support of unrelated hematopoietic cell transplantation
    E W Petersdorf
    Division of Clinical Research, Fred Hutchinson Cancer Research Ctr, Division of Clinical Research, and Department of Medicine, University of Washington, Seattle 98109 1024, USA
    Tissue Antigens 61:1-11. 2003
    ....
  14. ncbi request reprint Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation
    J S McCune
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Bone Marrow Transplant 30:167-73. 2002
    ..It may be possible to improve the outcome of HSCT in pediatric patients receiving the BU/CY regimen through optimization of busulfan C(SS) and better definition of the contribution of activated cyclophosphamide metabolites to toxicity...
  15. ncbi request reprint Identification of a novel HLA-B*07 allele--HLA-B*0726
    B Herbut
    Tissue Typing Laboratory, Calgary Laboratory Services, Foothills Medical Centre, Calgary, Canada
    Tissue Antigens 59:60-2. 2002
    ..This results in an amino acid substitution from arginine to leucine at residue 156 in exon 3...
  16. ncbi request reprint Seven new DPB1 alleles and their population distribution
    P V Moonsamy
    Department of Human Genetics, Roche Molecular Systems, Alameda, CA
    Tissue Antigens 43:249-52. 1994
  17. ncbi request reprint Population study of allelic diversity in the human MHC class I-related MIC-A gene
    E W Petersdorf
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, Seattle, WA 98109 1024, USA
    Immunogenetics 49:605-12. 1999
    ..These results confirm and extend previous knowledge on the polymorphism of MIC-A. The strong positive linkage of certain MIC-A and HLA-B alleles may have implications for studies related to MHC-associated diseases and transplantation...
  18. ncbi request reprint The biological significance of HLA-DP gene variation in haematopoietic cell transplantation
    E W Petersdorf
    Division of Clinical Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, D4 100, Seattle, WA 98109 1024, USA
    Br J Haematol 112:988-94. 2001
    ..1; P = 0.01). HLA-DP plays an important role in the alloimmune response. A threshold effect of multiple HLA-DP disparities is evident in determining the risk of acute GVHD after haematopoietic cell transplantation from unrelated donors...
  19. ncbi request reprint Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements
    J Pei
    Fred Hutchinson Cancer Research Center and the Department of Medicine, University of Washington, Seattle 98109-1024, USA
    Biol Blood Marrow Transplant 7:378-83. 2001
    ....
  20. ncbi request reprint Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience
    E W Petersdorf
    Fred Hutchinson Cancer Research Center, the U.S. National Marrow Donor Program, Georgetown University, Memorial Sloan Kettering Cancer Center, USA
    Blood 98:2922-9. 2001
    ..Furthermore, a good-risk population of patients whose transplantations were performed in the first CP of disease from HLA-A, B, DRB1 matched unrelated donors can be shown to have superior survival...
  21. ncbi request reprint Nomenclature for factors of the HLA system, 2004
    S G E Marsh
    Tissue Antigens 65:301-69. 2005
  22. ncbi request reprint Nomenclature for factors of the HLA system, 1998
    J G Bodmer
    ICRF Cancer and Immunogenetics Laboratory, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom
    Tissue Antigens 53:407-46. 1999
  23. ncbi request reprint Nomenclature for factors of the HLA system, 2004
    S G E Marsh
    Int J Immunogenet 32:107-59. 2005
  24. ncbi request reprint Unique sequences for two HLA-DRB1 genes expressed on distinct DRw6 haplotypes
    E W Petersdorf
    Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104
    Immunogenetics 32:96-103. 1990
    ....
  25. ncbi request reprint HLA-DRB1 first domain sequence for a novel DR4 allele designated DRB1*0413
    E W Petersdorf
    Fred Hutchinson Cancer Research Center, Seattle, Washington
    Tissue Antigens 40:267-8. 1992
    ..DRB1*0413 is a DRB1*0401-variant differing from DRB1*0401 only at codon 86 where valine is present instead of glycine...